Development of a miR-92a delivery system for anti-angiogenesis-based cancer therapy
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of a miR-92a delivery system for anti-angiogenesis-based cancer therapy
Authors
Keywords
-
Journal
JOURNAL OF GENE MEDICINE
Volume 15, Issue 1, Pages 20-27
Publisher
Wiley
Online
2012-12-14
DOI
10.1002/jgm.2690
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release
- (2012) Alain van Mil et al. CARDIOVASCULAR RESEARCH
- The microcosmos of cancer
- (2012) Amaia Lujambio et al. NATURE
- Integrin β3 Crosstalk with VEGFR Accommodating Tyrosine Phosphorylation as a Regulatory Switch
- (2012) Xiaoxia Z. West et al. PLoS One
- Dicetyl Phosphate-Tetraethylenepentamine-Based Liposomes for Systemic siRNA Delivery
- (2011) Tomohiro Asai et al. BIOCONJUGATE CHEMISTRY
- Inhibition of Akt (ser473) Phosphorylation and Rapamycin-Resistant Cell Growth by Knockdown of Mammalian Target of Rapamycin with Small Interfering RNA in Vascular Endothelial Growth Factor Receptor-1-Targeting Vector
- (2011) Hiroyuki Koide et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A
- (2011) C. Urbich et al. BLOOD
- Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis
- (2011) Long-gang Wang et al. Cancer Epidemiology
- Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3β
- (2011) Masaaki Tsukigi et al. CANCER LETTERS
- miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer
- (2011) Akihiko Tsuchida et al. CANCER SCIENCE
- MicroRNA-mediated regulation of the angiogenic switch
- (2011) Sudarshan Anand et al. CURRENT OPINION IN HEMATOLOGY
- Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac)
- (2011) Takeshi Yoshida et al. EXPERIMENTAL EYE RESEARCH
- MiR-17-92 cluster regulates cell proliferation and collagen synthesis by targeting TGFB pathway in mouse palatal mesenchymal cells
- (2011) Ling Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment
- (2011) Norihito Yonenaga et al. JOURNAL OF CONTROLLED RELEASE
- A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells
- (2011) Kim J. Png et al. NATURE
- MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis
- (2011) Qing Xu et al. NUCLEIC ACIDS RESEARCH
- Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease
- (2010) Qiuwang Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans
- (2010) Guo-Kun Wang et al. EUROPEAN HEART JOURNAL
- Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
- (2009) Zhaohui Huang et al. INTERNATIONAL JOURNAL OF CANCER
- Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients
- (2009) Masami Tanaka et al. PLoS One
- MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
- (2009) A. Bonauer et al. SCIENCE
- Disappearance of the angiogenic potential of endothelial cells caused by Argonaute2 knockdown
- (2008) Tomohiro Asai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
- (2008) Witold Filipowicz et al. NATURE REVIEWS GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now